# Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI

> **NCT03182855** · PHASE4 · UNKNOWN · sponsor: **University of Aarhus** · enrollment: 80 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Myocardial Infarction
- STEMI - ST Elevation Myocardial Infarction

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Cangrelor Tetrasodium

## Key facts

- **NCT ID:** NCT03182855
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-01
- **Primary completion:** 2019-06-01
- **Final completion:** 2019-08-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2018-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03182855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03182855, "Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03182855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*